Get startedLog in
    Picture of SynAct Pharma AB logo

    SYNACT — SynAct Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Synact Gets Patent Term Adjustment for Resomelagon Therapy

    Picture of SynAct Pharma AB logoSynAct Pharma AB
    12/05/2025 13:42
    May 12 (Reuters) - SynAct Pharma AB SYNACT.ST:

SYNACT RECEIVES ISSUE NOTIFICATION AND PATENT TERM ADJUSTMENT FOR US PATENT COVERING RESOMELAGON (AP1189) COMBINATION THERAPY

SYNACT RECEIVES ISSUE NOTIFICATION AND PATENT TERM ADJUSTMENT FOR US PATENT COVERING RESOMELAGON (AP1189) COMBINATION THERAPY

Source text: ID:nMFN5kKXXB

Further company coverage: SYNACT.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on SynAct Pharma AB

    See all news